COMMUNIQUÉS West-GlobeNewswire

Helix BioPharma Corp. Announces Fiscal Second Quarter 2018 Results
20/03/2018
RICHMOND HILL, Ontario, March 19, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FRANKFURT: HBP ) (“Helix” or the “Company”), a clinical stage immuno-oncology company developing innovative drug candidates [...]
PCI Biotech: Annual Report 2017
19/03/2018
Oslo (Norway), March 19, 2018 The Board of Directors of PCI Biotech Holding ASA has approved the Annual Report 2017 and the report is attached. The Annual Report 2017 is also available on the company's website www. [...]
Immunovaccine Researchers to Present New Preclinical Data at AACR Annual Meeting 2018
19/03/2018
HALIFAX, Nova Scotia, March 19, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that the Company will present research on the anti-cancer [...]
CohBar, Inc. to Announce 2017 Fourth Quarter Financial Results and Host Conference Call for Shareholders on April 2, 2018
19/03/2018
MENLO PARK, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR ) (TSXV:COB.U), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, [...]
Brainsway Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
19/03/2018
Increased market demand and new leasing model continue to generate significant sales growth Total minimum committed revenue projection is record $27 million for year-end 2017, up 142% versus year-end 2016 Strong balance [...]
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
19/03/2018
- Initiation of Phase 3 Programs in Geographic Atrophy (GA) and Paroxysmal Nocturnal Hemoglobinuria (PNH) Planned for 2018; Phase 2 Proof-of-Concept (POC) Data Anticipated in Autoimmune Hemolytic Anemia (AIHA) and [...]
AXIM Biotechnologies Reports Year End 2017 Results
19/03/2018
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced financial results for the quarter and year [...]
T2 Biosystems to Present at the 17th Annual Needham Healthcare Conference
19/03/2018
LEXINGTON, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]
aTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate Update
19/03/2018
SAN DIEGO, March 19, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]
Delcath to Present at Oppenheimer 28th Annual Healthcare Conference
19/03/2018
NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, [...]
Opiant Pharmaceuticals, Inc. to Present a Corporate Overview at the Oppenheimer 28th Annual Healthcare Conference
19/03/2018
SANTA MONICA, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, announced today [...]
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2018 Financial Results
19/03/2018
Highlights of the fiscal year include: Revenue of $229.5 million, an increase of 29% compared to FY17. Net income of $47.4 million, an increase of 80% compared to FY17. Net income per diluted share of $0.77, compared to [...]
AIT Therapeutics Reports Year End 2017 Financial Results
19/03/2018
Expects first regulatory filing for the NO Generator and Delivery System in persistent pulmonary hypertension of the newborn (PPHN) by end of 2018 Closed global, exclusive license for revolutionary NO Generator and [...]
Rhythm Pharmaceuticals Announces Presentation of Genetic Epidemiology of LEPR, POMC, And PCSK1 Variants at ENDO 2018
19/03/2018
BOSTON, March 19, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM ), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of [...]
Molecular Templates to Present at the Oppenheimer 28th Annual Healthcare Conference
19/03/2018
AUSTIN, Texas, March 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]
Avinger Announces Fourth Quarter and Full Year 2017 Results
19/03/2018
REDWOOD CITY, Calif., March 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported [...]
Emblem Selects No Fixed Address as its Agency of Record
19/03/2018
TORONTO, March 19, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (" Emblem " or the " Corporation ") is pleased to announce that it has selected No Fixed Address ( “NFA” ) as its agency of record, [...]
Soricimed annonce la nomination du Dr Marc Rubin et de M. Vaughn Embro-Pantalony à son conseil d’administration
19/03/2018
MONCTON, Nouveau-Brunswick, 19 mars 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. (« Soricimed »), compagnie pharmaceutique au stade clinique spécialisée dans la recherche et la mise au point de thérapies contre le [...]
Soricimed Announces the Appointment of Dr. Marc Rubin and Mr. Vaughn Embro-Pantalony to Board of Directors
19/03/2018
MONCTON, New Brunswick, March 19, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a clinical-stage pharmaceutical company discovering and developing targeted cancer therapeutics, is pleased to announce [...]

Pages